Evidence map›Paper›PMID 39800712›Full record

ArticleBMC health services research2025

Co-creation of a gender responsive TB intervention in Nigeria: a researcher-led collaborative study.

Chukwuebuka Ugwu, Oluwatoyosi Adekeye, Beate Ringwald, Rachael Thomson, Obioma Chijioke-Akaniro, Chukwuma Anyaike, S Bertel Squire, John Bimba, Tom Wingfield

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chukwuebuka UgwuLiverpool School of Tropical Medicine, Liverpool, UK. Chukwuebuka.ugwu@lstmed.ac.uk.
Oluwatoyosi AdekeyeZankli Research Centre, Bingham University, Karu, Nigeria.
Beate RingwaldLiverpool School of Tropical Medicine, Liverpool, UK.
Rachael ThomsonLiverpool School of Tropical Medicine, Liverpool, UK.
Obioma Chijioke-AkaniroObioma Chijioke-Akaniro, National Tuberculosis Leprosy and Buruli-Ulcer Control Programme, Federal Ministry of Health, Abuja, Nigeria.
Chukwuma AnyaikeObioma Chijioke-Akaniro, National Tuberculosis Leprosy and Buruli-Ulcer Control Programme, Federal Ministry of Health, Abuja, Nigeria.
S Bertel SquireLiverpool School of Tropical Medicine, Liverpool, UK.
John BimbaZankli Research Centre, Bingham University, Karu, Nigeria.
Tom WingfieldLiverpool School of Tropical Medicine, Liverpool, UK.

Funding

Dorothy Temple Cross Tuberculosis International Collaboration Grant from the Medical Research Foundation UK MRF-131-0006-RG-KHOS-C0942Medical Research Council, Public Health Intervention Development (PHIND) MR/Y503216/1Wellcome TrustWellcome Trust 209075/Z/17/Z
6 · The paper itself

Abstract

backgroundIn Nigeria, men constitute over half of the people notified with tuberculosis (TB), experience longer delays before reaching care, and are estimated to account for two thirds of people who miss out on care. The higher TB risk and burden in men has implications for the whole population and reaching them earlier with TB services will reduce onward transmission in households, communities, and workplaces. The absence of a comprehensive guidance and the lack of substantial empirical evidence on TB care approaches that are responsive to the needs of men in Nigeria exacerbates this problem. Therefore, this research aimed to co-create a gender-responsive intervention for men in peri-urban communities in Nigeria.

methodsOur study utilised a researcher-led collaborative approach to engage local TB stakeholders including communities adversely affected by the disease to co-create a gender-responsive TB intervention. Between March and November 2022, we engaged 13 local TB stakeholders in a three-phase participatory intervention design process. This engagement involved two iterative cycles of Delphi research online, and an in-person workshop. In the first and second phases, participants described the potential impact of 15 listed interventions and prioritised combinations of nine interventions deemed to be effective in overcoming identified gendered barriers. Responses were analysed using a combination of qualitative framework approach, content analysis, and summary descriptive statistics assisted by NVivo software. Stakeholder consensus on a preferred intervention package was reached during the participatory workshop.

resultsOverall, participants prioritised approaches that sought to actively find and systematically screen men for TB including awareness creation as a crucial component. The stakeholders placed significant considerations on the synergy between interventions and their programmatic sustainability when making their final choices. Consequently, a complex intervention package comprising three components was developed. These included targeted awareness creation among men in communities; TB screening in male-dominated socio-cultural congregate settings; and the use of digital chest X-ray screening. Anticipated early outputs of this intervention included improved TB knowledge, increased care-seeking, reduced TB-related costs and TB stigma, and accelerated early diagnosis among men in Nigeria.

conclusionLeveraging the insights and experiences of local stakeholders through iterative engagements yielded consensus on a viable gender-responsive TB intervention.

Indexed as

TuberculosisAdultCooperative BehaviorDelphi TechniqueFemaleHumansMaleNigeriaResearch PersonnelSex FactorsActive TB SurveillanceGender-ResponseParticipatory ResearchStakeholder Engagement

Identifiers

PMID39800712
PMCPMC11726931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.